Sharipov, R.A.,
Omarov, M.A.,
Mulyukov, A.R.,
Dybova, A.I.,
Vyaseleva, E.T.,
Kayumova, N.B.,
Saitgalina, A. Sh.,
Ententeev, K.R.,
Iagafarov, I.R.,
Kuserbaev, I.V.,
Gubaeva, E.A. (2023) provides prospects for the treatment of many neurodegenerative
diseases and cancers that were previously
Beylerli, Ozal,
Ju, Jiaming,
Beilerli, Aferin,
Gareev, Ilgiz,
Shumadalova, Alina,
Ilyasova, Tatiana,
Bai, Yunlong,
Yang, Baofeng (2023) with structural heart
disease and is a significant cause of morbidity and mortality in clinical settings. AF
Sufianov, Albert,
Beilerli, Aferin,
Kudriashov, Valentin,
Ilyasova, Tatiana,
Wenjie, Bu,
Beylerli, Ozal (2023) delivery
systems and lead to improvement of the efficiency of many new biopharmaceuticals. Designing
Urakov, Aleksandr L.,
Tyurin, Anton V.,
Shchekin, Vlas S.,
Siddikov, Olim A.,
Abdurakhmanov, Ilhomjon R.,
Gabdrakhimova, Renata A.,
Samorodov, Aleksandr V. (2024) of
diseases is assigned to the mechanisms of epigenetic regulation and posttranslational modifications
Kudoyarov, E.R.,
Karimov, D.O.,
Bakirov, A.B.,
Mukhammadieva, G.F.,
Karimova, L.K.,
Galimova, R.R. (2022) somatic
diseases. Given that, prevention of chronic non-communicable
diseases in workers employed